CT-guided liver biopsies: eight years' experience. Work in progress

Radiology. 1984 Sep;152(3):755-7. doi: 10.1148/radiology.152.3.6463257.

Abstract

In the past eight years 180 patients with liver abnormalities demonstrated on computed tomography (CT) underwent CT-guided biopsies with 22-guage Madayag, 14-gauge Travenol, or 18-gauge Menghini needles used singly or in combination. Cytologic and pathologic results were tabulated and correlated with the subsequent surgical or autopsy findings and with clinical follow-up ranging from three months to three years. Complications of the procedures were also recorded. It is concluded that cutting needle biopsies provide a higher yield of diagnostic tissue compared with aspiration biopsies (89.9% versus 65%) without a significant increase in complications (1.44% versus 0.83%). The techniques utilized, risk of complications, and the indications for biopsy are discussed.

Publication types

  • Comparative Study

MeSH terms

  • Biopsy / adverse effects
  • Biopsy / methods
  • Biopsy, Needle / adverse effects
  • Biopsy, Needle / instrumentation
  • Biopsy, Needle / methods
  • Diatrizoate Meglumine
  • Follow-Up Studies
  • Humans
  • Liver / diagnostic imaging*
  • Liver / pathology
  • Liver Diseases / diagnosis
  • Liver Diseases / pathology
  • Needles
  • Tomography, X-Ray Computed*

Substances

  • Diatrizoate Meglumine